ConductScience.org, home
VTCN1: V-set domain containing T cell activation inhibitor 1
API referenceFor AI assistants

Gene · 79679

Papers2,409

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 2,409

Download this page as JSON
TitleJournalYearPMIDFound bySource
[Special tumor entities : New results at the 2026 ASCO Annual Meeting].HNO202642814119PubTator, text miningPubMed
Time to Rethink Pathology Reporting in Adenoid Cystic Carcinoma.Head Neck202642811719PubTator, text miningPubMed
A study on the mechanism of action of B7H4 in HER2-positive gastric cancer and its sensitivity to trastuzumab therapy.Transl Cancer Res202642724573PubTator, text miningPubMed
Membrane and soluble VTCN1 (B7H4) converge on Src signaling to mediate gemcitabine resistance in intrahepatic cholangiocarcinoma.Theranostics202642708082PubTator, text miningPubMed
Pre-treatment T-cell Transcriptional Signatures Predict Immunotherapy Outcomes in Melanoma.Res Sq202642687902PubTator, text miningPubMed
Nardilysin: classical functions and new horizons in autoimmunity.Front Immunol202642676835PubTator, text miningPubMed
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.Nat Commun202642624861PubTator, text miningPubMed
European Society for Medical Oncology Gynaecological Cancers Congress 2026: key scientific advances from the oral sessions.Int J Gynecol Cancer202642624675PubTator, text miningPubMed
B7-H4 enrichment represents a site-specific immunotherapy target in small bowel gastrointestinal stromal tumors.bioRxiv202642620335PubTator, text miningPubMed
Antibody drug conjugates in gynaecological cancers: navigating between opportunities and challenges.EClinicalMedicine202642534594PubTator, text miningPubMed
Ubiquitin-driven regulation of immune checkpoints in lung cancer: Mechanisms and therapeutic implications (Review).Exp Ther Med202642524104PubTator, text miningPubMed
Immune checkpoint profiling of B7-H proteins predicts survival and treatment response in metastatic clear cell renal cell carcinoma.J Pathol Clin Res202642473284PubTator, text miningPubMed
HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression.Cancer Immunol Immunother202642469430PubTator, text miningPubMed
Tissue Factor-High Ovarian Clear Cell Carcinoma Shows Immune-Cold Features and Preclinical Activity of Tisotumab Vedotin.Cancer Sci202642437863PubTator, text miningPubMed
B7-H4-targeted radiotheranostics enable precise imaging and potent therapy across solid tumor models.Sci Adv202642384807PubTator, text miningPubMed
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.Mol Cancer Ther202642374845PubTator, text miningPubMed
[225Ac]Ac-Macropa-PEG4-FPA150 enables targeted alpha therapy of B7-H4-Expressing tumors.Appl Radiat Isot202642365835PubTator, text miningPubMed
Comprehensive analysis of antibody-drug conjugate (ADC) targets in adenoid cystic carcinoma: examining antigen expression in relation to clinicopathological features, prognosis, and initial therapeutic outcomes.
Transl Oncol202642341371PubTator, text miningPubMed
Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis.J Hepatocell Carcinoma202642326610PubTator, text miningPubMed
Histology-specific ADC target landscapes in ovarian cancer and therapy-associated antigen downshift after ADC exposure.Gynecol Oncol202642235136PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/79679/papers

API referenceFor AI assistants